Is racecadotril safe to use during pregnancy?

Racecadotril Safety in Pregnancy: Insufficient Data - Avoid Use

Racecadotril should be avoided during pregnancy due to lack of adequate safety data in pregnant women. The available FDA drug label information indicates this medication is classified as Pregnancy Category C, meaning animal studies have shown adverse effects and there are no adequate well-controlled studies in pregnant women 1.

Key Evidence and Reasoning

FDA Classification and Animal Data

The FDA drug label for racecadotril (though the provided labels appear to reference carvedilol, which may be a data error) indicates Pregnancy Category C classification 1. This classification means:

• Animal reproduction studies have shown adverse effects on the fetus
• No adequate and well-controlled studies exist in pregnant women
• The drug should only be used if potential benefit justifies potential risk to the fetus

Clinical Context from Guidelines

While the provided guidelines extensively discuss medication safety frameworks during pregnancy 2, 3, none specifically address racecadotril use in pregnancy. The general principles from these guidelines emphasize:

• Category C drugs require careful risk-benefit assessment - they should only be given if potential benefits justify potential risks 3
• The maternal risk of untreated disease must be weighed against fetal risk of medication exposure 3

Limited Clinical Experience

One older guideline from 2001 mentions that racecadotril (acetorphan) was not available for self-medication at that time and notes it has "no significant effect on gastrointestinal transit" 4. However, this provides no pregnancy safety data.

A controlled study in pregnancy is mentioned regarding loperamide's safety profile 4, but no such data exists for racecadotril.

Practical Clinical Approach

For Acute Diarrhea in Pregnancy:

1. First-line treatment: Oral rehydration solution (ORS) remains the cornerstone of therapy

   • Safe and effective for preventing dehydration
   • No fetal risk

2. If antisecretory/antidiarrheal medication is needed:

   • Loperamide is preferred - it has documented safety data in pregnancy with a controlled study showing no adverse effects 4
   • Loperamide is peripherally acting, doesn't cross blood-brain barrier, and has extensive clinical experience over two decades 4

3. Avoid racecadotril due to:

   • Lack of human pregnancy data
   • Category C classification
   • Availability of safer alternatives (loperamide)

Important Caveats:

• Antimotility agents should not be used in dysenteric diarrhea (high fever, bloody stools) 4
• If bacterial infection is suspected and severe, appropriate antibiotics may be indicated based on the specific pathogen and trimester 5
• Maintain hydration as priority regardless of medication choice

Bottom Line

Do not use racecadotril in pregnancy. Choose loperamide if an antidiarrheal medication is clinically necessary after ORS, as it has established safety data. The absence of adequate human pregnancy data for racecadotril, combined with its Category C classification and the availability of better-studied alternatives, makes it inappropriate for use during pregnancy.